# The TRUST Trial - CardioVascular Imaging ECHO

Study · id `cardio:ct-nct02832960` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02832960](<https://clinicaltrials.gov/study/NCT02832960>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02832960

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease; Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 185 participants.

## Technical summary

Registry record NCT02832960. Randomized; quadruple masking; primary purpose treatment. Start 2016-06 (registry gives no type); primary completion 2016-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 185 participants (enrolled count; ClinicalTrials.gov record NCT02832960, source copy `cardio:ctgov-nct02832960-2017-02-28`, retrieved 2026-10-26)
- Start date: 2016-06 (registry gives no type) (ClinicalTrials.gov record NCT02832960, source copy `cardio:ctgov-nct02832960-2017-02-28`, retrieved 2026-10-26)
- Primary completion: 2016-12 (actual) (ClinicalTrials.gov record NCT02832960, source copy `cardio:ctgov-nct02832960-2017-02-28`, retrieved 2026-10-26)
- Completion: 2016-12 (actual) (ClinicalTrials.gov record NCT02832960, source copy `cardio:ctgov-nct02832960-2017-02-28`, retrieved 2026-10-26)
- Countries: Switzerland (ClinicalTrials.gov record NCT02832960, source copy `cardio:ctgov-nct02832960-2017-02-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02832960-2017-02-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: The TRUST Trial - CardioVascular Imaging ECHO
- Condition: Thyroid Dysfunction
- Condition: Atherosclerosis
- Condition: Heart Failure
- Intervention (Drug): Levothyroxine
- Intervention (Drug): Placebo
- Lead sponsor: Insel Gruppe AG, University Hospital Bern
- Lead sponsor class: OTHER
- Collaborator: University of Lausanne Hospitals
- Collaborator class: OTHER
- Collaborator: University Hospital, Geneva
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Insel Gruppe AG, University Hospital Bern (`cardio:org-insel-gruppe-ag-university-hospital-bern`)
- Registry lists this organization as a collaborator: University of Lausanne Hospitals (`cardio:org-university-of-lausanne-hospitals`)
- Registry lists this organization as a collaborator: University Hospital, Geneva (`cardio:org-university-hospital-geneva`)

## Provenance

Content hash: 8d502e9eb65a04154dc4ba9c12f2d5af51f1de5a9d567404f834b4258208c2c7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
